Mirae Asset Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹2770 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 15% |
| Expense Ratio | 1.81 | 1.93 |
| Manager | Sailesh Raj Bhan | Vrijesh Kasera |
| ISIN Code | INF204K01968 | INF769K01EA2 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | -3.66% | -2.94% |
| 6 Month | 7.39% | 9.21% |
| 1 Year | 21.43% | 27.15% |
| 3 Year | 19.27% | 17.72% |
| 5 Year | 25.83% | 26.58% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 14.69% | 19.44% |
| 3 Year | 27.2% | 27.17% |
| 5 Year | 22.9% | 22.97% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 17.79% | 23.48% |
| 3 Year | 20.87% | 20.47% |
| 5 Year | 20.18% | 23.92% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.65% |
| Sharp | 0.78% | 0.62% |
| Beta | 0.87% | 0.95% |
| Alpha | 1.67% | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Vrijesh Kasera |
| Total AUM | ₹96086 Cr | ₹12061 Cr |
| Fund Manage | 5 | 4 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.4 | 0.92 |
| Large Cap | 45.96 | 43.94 |
| Mid Cap | 27.12 | 34.94 |
| Small Cap | 22.52 | 20.21 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.4 | 0.92 |
| Pharmaceuticals & Biotechnology | 75.86 | 81.65 |
| Healthcare Services | 17.38 | 16.07 |
| Retailing | 2.36 | - |
| Chemicals & Petrochemicals | - | 1.37 |
Top Comparisons
ADITYA BIRLA SUN LIFE US TREASURY 3 10 YEAR BOND ETFS FUND OF FUNDS REGULAR PLAN GROWTH
3Y Returns0%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns18.21%
Mahindra Manulife Mid Cap Fund - Regular Plan - Growth
3Y Returns20.88%
HDFC Mid-Cap Opportunities Fund - Growth Plan
3Y Returns24.33%
Aditya Birla Sun Life Flexi Cap Fund - Growth - Regular Plan
3Y Returns12.5%
360 ONE FlexiCap Fund Regular - Growth
3Y Returns0%
BANDHAN Government Securities Fund - IP - Regular Plan - Growth
3Y Returns6.33%
SBI Magnum Gilt Fund - Regular Plan - Growth
3Y Returns7.03%